Literature DB >> 15249664

Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C.

Tobias N Dechow1, Laura Pedranzini, Andrea Leitch, Kenneth Leslie, William L Gerald, Irina Linkov, Jacqueline F Bromberg.   

Abstract

Persistently activated Stat3 is found in many different cancers, including approximately 60% of breast tumors. Here, we demonstrate that a constitutively activated Stat3 transforms immortalized human mammary epithelial cells and that this oncogenic event requires the activity of matrix metalloproteinase-9 (MMP-9). By immunohistochemical analysis, we observe a positive correlation between strong MMP-9 expression and tyrosine phosphorylated Stat3 in primary breast cancer specimens. These results demonstrate a relationship between activated Stat3 and MMP-9 in breast oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15249664      PMCID: PMC489981          DOI: 10.1073/pnas.0404100101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  Stat proteins and oncogenesis.

Authors:  Jacqueline Bromberg
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 2.  New functions for the matrix metalloproteinases in cancer progression.

Authors:  Mikala Egeblad; Zena Werb
Journal:  Nat Rev Cancer       Date:  2002-03       Impact factor: 60.716

3.  Stat3 as an oncogene.

Authors:  J F Bromberg; M H Wrzeszczynska; G Devgan; Y Zhao; R G Pestell; C Albanese; J E Darnell
Journal:  Cell       Date:  1999-08-06       Impact factor: 41.582

4.  Matrix metalloproteinases in neoplasm-induced extracellular matrix remodeling in breast carcinomas.

Authors:  B Bodey; B Bodey; S E Siegel; H E Kaiser
Journal:  Anticancer Res       Date:  2001 May-Jun       Impact factor: 2.480

5.  Proximal events in signaling by plasma membrane estrogen receptors.

Authors:  Mahnaz Razandi; Ali Pedram; Steven T Park; Ellis R Levin
Journal:  J Biol Chem       Date:  2002-11-05       Impact factor: 5.157

6.  Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer.

Authors:  Andreas Widschwendter; Sibylle Tonko-Geymayer; Thomas Welte; Günter Daxenbichler; Christian Marth; Wolfgang Doppler
Journal:  Clin Cancer Res       Date:  2002-10       Impact factor: 12.531

7.  Gelatinase levels in male and female breast cancer.

Authors:  Gianluigi Giannelli; Emilia Fransvea; Felice Marinosci; Carlo Bergamini; Antonella Daniele; Silvia Colucci; Angelo Paradiso; Michele Quaranta; Salvatore Antonaci
Journal:  Biochem Biophys Res Commun       Date:  2002-03-22       Impact factor: 3.575

8.  Gastrin-stimulated gastric epithelial cell invasion: the role and mechanism of increased matrix metalloproteinase 9 expression.

Authors:  Lydia E Wroblewski; David M Pritchard; Stuart Carter; Andrea Varro
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

9.  Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity.

Authors:  Emilio Fiore; Carlo Fusco; Pedro Romero; Ivan Stamenkovic
Journal:  Oncogene       Date:  2002-08-08       Impact factor: 9.867

10.  Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer.

Authors:  Miaw-Sheue Tsai; Lisa A Shamon-Taylor; Inderjit Mehmi; Careen K Tang; Ruth Lupu
Journal:  Oncogene       Date:  2003-02-06       Impact factor: 9.867

View more
  103 in total

1.  STAT3 can serve as a hit in the process of malignant transformation of primary cells.

Authors:  M Demaria; S Misale; C Giorgi; V Miano; A Camporeale; J Campisi; P Pinton; V Poli
Journal:  Cell Death Differ       Date:  2012-03-09       Impact factor: 15.828

2.  MMP9 polymorphisms and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study.

Authors:  Alicia Beeghly-Fadiel; Wei Lu; Xiao-Ou Shu; Jirong Long; Qiuyin Cai; Yongbin Xiang; Yu-Tang Gao; Wei Zheng
Journal:  Breast Cancer Res Treat       Date:  2010-08-20       Impact factor: 4.872

3.  Blockade of recombinant human IL-6 by tocilizumab suppresses matrix metalloproteinase-9 production in the C28/I2 immortalized human chondrocyte cell line.

Authors:  Evan C Meszaros; Wissam Dahoud; Sam Mesiano; Charles J Malemud
Journal:  Integr Mol Med       Date:  2015-08-08

4.  Transcriptional regulation by a DNA-associated form of cyclin D1.

Authors:  Frédéric Bienvenu; Benjamin Barré; Sandrine Giraud; Sylvie Avril; Olivier Coqueret
Journal:  Mol Biol Cell       Date:  2005-01-19       Impact factor: 4.138

5.  Loss of androgen receptor expression promotes a stem-like cell phenotype in prostate cancer through STAT3 signaling.

Authors:  Anne Schroeder; Andreas Herrmann; Gregory Cherryholmes; Claudia Kowolik; Ralf Buettner; Sumanta Pal; Hua Yu; Gerhard Müller-Newen; Richard Jove
Journal:  Cancer Res       Date:  2013-10-31       Impact factor: 12.701

Review 6.  Role of STAT3 in Genesis and Progression of Human Malignant Gliomas.

Authors:  Zangbéwendé Guy Ouédraogo; Julian Biau; Jean-Louis Kemeny; Laurent Morel; Pierre Verrelle; Emmanuel Chautard
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

Review 7.  Inflammation: a driving force speeds cancer metastasis.

Authors:  Yadi Wu; Binhua P Zhou
Journal:  Cell Cycle       Date:  2009-10-03       Impact factor: 4.534

8.  Bortezomib enhances antigen-specific cytotoxic T cell responses against immune-resistant cancer cells generated by STAT3-ablated dendritic cells.

Authors:  Jee-Eun Kim; Dong-Hoon Jin; Wang Jae Lee; Daeyoung Hur; T-C Wu; Daejin Kim
Journal:  Pharmacol Res       Date:  2013-02-18       Impact factor: 7.658

9.  Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling.

Authors:  Amita Sneh; Yadwinder S Deol; Akaansha Ganju; Konstantin Shilo; Thomas J Rosol; Mohd W Nasser; Ramesh K Ganju
Journal:  Breast Cancer Res Treat       Date:  2013-03-28       Impact factor: 4.872

10.  The DEAD box protein p68: a novel coactivator of Stat3 in mediating oncogenesis.

Authors:  M Sarkar; V Khare; M K Ghosh
Journal:  Oncogene       Date:  2016-12-12       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.